DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Monday, 26 September 2016

Dr. Mahaletchumy Arujanan

F62d

Dr. Mahaletchumy Arujanan

The Klang-born biotechnologist was recently nominated in the Top 100 most influential people in her particular field. She helped develop resolution for Muslim countries on the use of genetic modifications (GM) through dialogues with religious scholars. She is internationally active in influencing policies, regulations and biotechnology communication to ensure the potential of this field benefits agriculture, medical and industrial sectors.

  • How did she do it?

    "We are not completely atheists or free thinkers, so ethics and religion here are important. So we have to see like cloning, what is it for, why do you want to do it? There are so many issues.

    We engage ulamas as well. So what we did here was to organise a dialogue with scientists and ulamas. We wanted scientists to understand what are the Islamic principles and the ulamas to understand what exactly happens in these science processes. Ulamas will be able to make decisions not just based on Shariah principles but also scientific knowledge.

    In the Philippines, there was this blanket fatwa from the Ulama Council saying that all genetic modification (GM) is haram. We had these dialogues with the ulamas and we came up with this resolution. So then, the Philippines lifted their fatwa and said it is haram only if the genes come from porcine sources… many countries were watching and read the resolution we came up with and they started being more open to biotech. Malaysia also has a fatwa that says the same thing. GM is allowed only if the source is not porcine. Which is fair to all."
Mahaletchumy Arujanan

About

I am the Executive Director of MABIC and Editor-in-Chief of The Petri Dish: the 1st science newspaper in Malaysia. I won the 2010 TWAS Regional Prize for Public Understanding of Science for East, SEA and Pacific Region. As a pioneer in science communication in Malaysia, I built strong network among local and international stakeholders. I serve on several committees related to biotech education, policies and regulations. My interest is also on non-traditional approaches in communicating biotech.

Summary

- Transformed MABIC into an active and effective organisation that enhances public understanding of biotechnology, both locally and in the region
- Rebranded MABIC as a credible organisation that provides recommendations, direction and advice on biotechnology development in Malaysia.
- One of the major accomplishments is making MABIC partially financially self-sufficient through projects that are able to generate revenue.
- Successfully collaborated and created a link with all major biotech stakeholders in Malaysia, e.g. universities, research institutes, ministries, and government agencies
- Introduced non-traditonal approaches in communicating biotech, e.g. carnival, fashion show, school competitions
- Organized a large number of seminars, conferences, workshops, forum on creating awareness on biotechnology and in providing direction for biotechnology and bioeconomy development in Malaysia
- Managed to raise fund from both national and international organisations and agencies for Public Understanding of Biotechnology
- Listed as the 1100 most influential person in biotechnology in the world by Scientific American WorldView (2015)
- Listed as "Women in Biotechnology Law and Regulation" by Biotech Law Report (2015), Mary Ann Liebert, USA.
- Received the 2010 TWAS Regional Prize for Public Understanding of Science for Southeast, East and Pacific Region

Specialties: Biotechnology Communication, Regulations and Policies, Fund-raising, management and administration

Mahaletchumy Arujanan is a Malaysian scientist of Indian origin. She currently works as an executive director of Malaysian Biotechnology Information Centre (MABIC).
Arujanan was born in Klang Valley, Malaysia in year 1969 to a Tamil school headmaster.[1] She has a bachelor degree in biochemistry and microbiology from University Putra Malaysia, and a Masters in Biotechnology and PhD in Science Communication from University of Malaya. She joined MABIC in Jan 2003 as a project officer and later took over as the executive director in May 2005.[2] She was listed as one of the 100 most influential people in the field of biotechnology by the 7th edition of The Scientist American Worldwide View: A Global Biotechnology Perspective Journal.[3] She founded the country’s first biotechnology newspaper, The Petri Dish. She is a recipient of 2010 TWAS Regional Prize for Public Understanding of Science for East, Southeast Asia and Pacific Region, and has been listed as one of the prominent women in biotechnology law and regulations by Biotechnology Law Report.[4]

Experience

Executive Director

Malaysian Biotechnology Information Centre

 – Present (13 years 9 months)Bandar Sunway, Selangor, Malaysia
(Open)1 project
(Open)2 honors and awards
(Open)7 recommendations, including:
  • Behzad Ghareyazie

Behzad Ghareyazie
Founder, Agricultural Biotechnology Research Institute of Iran (ABRII)

  • Dr. Mahaletchumy Arujanan or as we call her; Maha is an example of a well organized, science oriented, well educated and...View
  • Piero Morandini

Piero Morandini
Researcher in Plant Physiology at University of Milan

  • Maha is a dedicated worker, well prepared to perform the tasks entrusted to her and with a broad understanding of the issues...View
5 more recommendations

Editor-in-Chief (The Petri Dish)

Malaysian Biotechnology Information Centre

 – Present (5 years 9 months)
Initiated the first popular science newspaper in Malaysia. Aimed at bringing life sciences/biotechnology to the public domain to create better understanding and appreciation on this subject. Petri Dish is an organ for the scientific community to talk about their research. The newspaper covers all aspects of biotechnology - the science and research, commercialisation and business, regulations and policies, and ethics and religion. It plays a key role in inspiring students in STEM.

Petri Dish is distributed to research institutes, universities, schools, ministries and government agencies, biotech industry, ministers, hospitals and is available at Starbucks outlets.

Adjunct Lecturer

Monash University Sunway Campus

 – Present (1 year 2 months)Bandar Sunway, Selangor, Malaysia
Teach Module on Science Communication. Enhance the School of Science's engagement with biotechnology industry and link them to potential collaborators.

Trainer

Industry Cluster of Excellence, Universiti Malaysia Pahang

 – Present (2 years)
Train undergraduates and post graduates in life sciences on biotechnology development and career prospects.

This is aimed at inspiring students excel in their science careers and guiding them on their career path.

Trainer/Consultant

Malaysian Biotechnology Corporation

 – Present (4 years 9 months)Kuala Lumpur, Malaysia
Train graduates in public and private universities under the Biotechnology Entrepreneurship Special Training (BeST) programme to support Human Capital and Entrepreneur Development for the biotech sector.

It is aimed at preparing graduates to be market-ready and inspire them to excel in their chosen careers.

Education

University of Malaya

PhD, Science Communication

University of Malaya

M. Biotechnology, Biotechnology

Universiti Putra Malaysia

B.Sc (Hons), Biochemistry and Microbiology

- Received scholarship from the Malaysian Tobacco Company

References

  1. Jump up^ Kamlesh Kumar (27 September 2015). "10 things about: Mahaletchumy Arujanan, biotechnologist putting Malaysia on the world map"Malay Mail. Retrieved 8 February 2015.
  2. Jump up^ http://www.bic.org.my/about-us/team
  3. Jump up^ Wani Mutthiah (20 June 2015). "Scientist from Klang does country proud"The Star. Retrieved 8 February 2015.
  4. Jump up^ "Women in Biotechnology Law and Regulation"Biotechnology Law Report. 1 June 2015. pp. 107–118. doi:10.1089/blr.2015.28999. Retrieved 15 August 2016


Dr Mahaletchumy Arujanan


Image result for Mahaletchumy ArujananImage result for Mahaletchumy Arujanan


Image result for Mahaletchumy Arujanan

Image result for Mahaletchumy Arujanan
////////

Associate Professor Lim Lee Wei

Associate Professor Lim Lee Wei. The Malaysian born scientist from Sunway University discovered that deep brain stimulation can help reduce the symptoms of dementia.

  • How did he do it?

    The preliminary study was conducted while he was a research fellow at Maastricht and Oxford University, and the findings were also published recently in the Translational Psychiatry, a journal of the Nature Publishing Group, by Macmillan Publishers Limited.

    For memory enhancement, bilateral electrodes were implanted in the prefrontal cortex, a key brain structure for regulation of emotion, cognition and decision making.

    After chronic stimulation, the research team found a significant improvement on both the short- and long-term memory functions in animals, using well-validated behavioural memory tasks.

    ‘Although the findings from present experimental model show promising results, validation in the clinical studies is essential to determine its efficacy. Nevertheless, this is a major step forward on the journey towards combating dementia in humans’,said the vice-chancellor of Sunway University, Professor Graeme Wilkinson.

Dr. Pei Cheng Chua

Dr. Pei Cheng Chua. The Malaysian scientist recently won the Birkeland Prize for her thesis in the field of oil and gas. Her research led to the design of new Low Dosage Hydrate Inhibitors that are more environmentally friendly.

  • How did she do it?

    Dr. Chua's research focuses on how natural gas combined with produced water under high pressure and low ambient seabed temperatures can form hydrates and cause gas hydrate plugging, which in the worst case can completely halt the flow. Chua has designed, produced and pressure tested new Low Dosage Hydrate Inhibitors which have proved to perform better and have less environmental impact than products currently on the market.

    “I hope that my research help to further develop the development of gas hydrate inhibitions, and furthermore becomes a good environmental friendly product,” Dr. Chua said. “I was in doubt if I should work in the oil & gas industry due to the impact this sector has on the environment. But we cannot eliminate the use of oil & gas overnight, and we need to overcome the gas hydrate problem industry, so I wanted to find better and more green ways to do it,” she explains.

Wednesday, 21 September 2016

Manoj C. Desai, PhD

.


Dr. Manoj Desai began his professional career in the pharmaceutical industry at Pfizer Inc, Central  Research  Division,  Groton,  CT  (1986-1994)  before  moving  to  Chiron  Corporation (1994-2003) as Director of medicinal chemistry.  In October 2003, he was appointed Vice President of medicinal chemistry at Gilead Sciences.  At Pfizer, he was responsible for the medicinal chemistry efforts that lead to the discovery of oral Substance P antagonist CP-99994 which became the basis for the discovery of the new anti-emetics.  At Chiron he formulated macrobead technology  for  the  synthesis  and  screening  of  compound  libraries  for  high through put screening  and  directed research efforts for the discovery of kinase inhibitors.   His research efforts at Gilead led to the discovery of cobicistat which is one of components of Stribild® that was approved by FDA for the treatment of HIV infection.  He is co-inventor on patents of cobicistat and ledipasvir. Cobicistat is a pharmacoehancer devoid of antiviral activity.  He is co-inventor on patents of cobicistat and ledipasvir.   Cobicistat has been coformulated in four approved therapies for the treatment of HIV: Stribild®and Genvoya® (marketed by Gilead), Prezcobix® (marketed by Johnson & Johnson), Evotaz® (marketed by Bristol-Myers Squibb).  Ledipasvir is a part of two-drug regimen in Harvoni® for curing Hepatitis C virus. 
Dr. Desai obtained Ph.D. in organic chemistry from the M. S. University of Baroda in 1981 working with Dr. Sukh Dev and then carried out post-doctoral fellowships at Purdue University (Professor Herbert C. Brown, 1981-1983) and at Harvard University (Professor Elias J. Corey, 1983-1986). 
He has co-authored more than 60 publications in peer reviewed journals and is an inventor on more than 25 issued patents. Furthermore, Dr. Desai is Editor-in-Chief for Medicinal Chemistry Reviews (renamed from Annual Reports in Medicinal chemistry; 2012-current), and has co-edited Comprehensive Medicinal Chemistry II (volume 7, 2007) and a book titledSuccessful Strategies for the Discovery of Antiviral Drugs (2013).














///////////////

Thursday, 15 September 2016

Dr. Balasaheb M. More





Balasaheb More Ph.D.

Manager - Process innovation at Dr. Reddy's laboratories
 Dr. Reddy's Laboratories


LINKS AND CONTACTS
Dr. Balasaheb M. More
 Face book More Balasaheb M







M.Sc. Ph. D. Chemistry & currently working with Dr. Reddy’s laboratories, Hyderabad as Manager-R&D.He has total 17 years of experience in API Research and development in pharmaceutical companies.  He wants to take new challenges in the research field. 
He is interested in finding a suitable position where I can use my skills in research and development. 
He has a broad range of skills, including:
*  Adept in synthetic organic chemistry with expertise in design of non-infringing, cost effective, scalable and safe synthetic route in line with QbD.
*  Generating standard scientific documents related to pre and post-product development phases.
*  Capability to drive process robustness & cost reduction projects of commercialised HRM & LRM products.
*  Review and response to queries from various regulatory authorities.
*  Practicing and implementing GLP, GMP and SHE policies.
*  Excellent Project management & ability to collaborate with cross-functional teams.
*  Leading a team of 15 scientist.


Experience






Manager - Process innovation

Dr. Reddy's Laboratories
– Present (9 years 3 months)Hyderabad Area, India
Responsible to Identify, develop and implement new R&D projects and technologies, Development & optimization of HPAI & API processes, keeping view of commercial and quality aspect. Provide technical guidance to team members and coordinate with other departments. Investigation of OOS/OOT batches, catalysts recovery & trouble shooting in production batches etc. Involved in API Cost improvement of HRM & LRM products and process robustness projects. Evaluation and Implementation of PAT tecnologies in the processes.





Research Officer

Glenmark Pharmaceuticals
(1 year 4 months)Mumbai, India
Process development of Active pharmaceutical ingredients through various phases like literature search for the optimization of synthetic methodology and design schemes for possible execution of the synthesis, Conduct feasibility, optimisation, laboratory validation experiments, and demonstrating process at production level. Support for DMF filing documents




Assistant Manager

Laxmi Organic Industries Ltd.
(8 months)Mumbai Area, India





Project Coordinator

Hi Tech BioSciences India Ltd.
(5 years 1 month)Pune Area, India
Attachments area

,
 With Dr Balasaheb, Dr Anil Kumar, IIT-B,  at IISER-PUNE, Pune INDIA on 27 Aug 2016 for Flow Chemistry Symposium + Workshop ...



Education





Andhra University

Doctor of Philosophy (Ph.D.)

SYNTHESIS AND CHARACTERISATION OF THIENOPYRIDINE SULPHONAMIDES, PIPERAZINE & PIPERIDINE CONTAINING NITROSO UREA ANALOGUES AND THEIR IN VITRO BIO-EVALUATION (ANTIMICROBIAL AND ANTICANCER ACTIVITY) BESIDES DEVELOPMENT OF A NEW SYNTHETIC METHODOLOGY.




University of Pune

Master’s Degree

M.Sc. Organic Chemistry




University of Pune

Bachelor’s Degree, Chemistry



Patents






WO2008117305-A NOVEL PROCESS FOR PREPARING PREGABALIN AND ITS ACID ADDITION SALTS

United States
Issued
 
 
 
 
HIS CV
SCROLL USING CURSOR TO VIEW FULL CV


HIS CV
SCROLL USING CURSOR TO VIEW FULL CV


//////////